These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Primary prevention trials in Alzheimer disease. Green RC; DeKosky ST Neurology; 2006 Nov; 67(9 Suppl 3):S2-5. PubMed ID: 17101930 [TBL] [Abstract][Full Text] [Related]
3. Prevention trials in Alzheimer disease: one step forward? Touchon J; Portet F; Gauthier S Neurology; 2006 Nov; 67(9 Suppl 3):S21-2. PubMed ID: 17101931 [TBL] [Abstract][Full Text] [Related]
4. Prevention of Alzheimer's Disease: Lessons Learned and Applied. Galvin JE J Am Geriatr Soc; 2017 Oct; 65(10):2128-2133. PubMed ID: 28766695 [TBL] [Abstract][Full Text] [Related]
5. Drug discovery and the prevention of Alzheimer's disease. Fillit H Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S26-8. PubMed ID: 18631996 [TBL] [Abstract][Full Text] [Related]
12. Prevention studies in Alzheimer's disease: progress towards the development of new therapeutics. Coley N; Gallini A; Andrieu S CNS Drugs; 2015 Jul; 29(7):519-28. PubMed ID: 26188654 [TBL] [Abstract][Full Text] [Related]
13. The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint. Vellas B; Andrieu S; Ousset PJ; Ouzid M; Mathiex-Fortunet H; Neurology; 2006 Nov; 67(9 Suppl 3):S6-11. PubMed ID: 17101932 [TBL] [Abstract][Full Text] [Related]
15. Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives. Wang J; Tan L; Yu JT J Alzheimers Dis; 2016; 50(4):927-45. PubMed ID: 26836177 [TBL] [Abstract][Full Text] [Related]
16. Designing a large prevention trial: statistical issues. Kryscio RJ; Mendiondo MS; Schmitt FA; Markesbery WR Stat Med; 2004 Jan; 23(2):285-96. PubMed ID: 14716729 [TBL] [Abstract][Full Text] [Related]